HealthcarePharmaceuticals & BiotechnologyPharmaceuticals

Caplin Point Laboratories Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 58 filings·Updated 7 Oct 2026
Showing 10 of 58 filings.
7 Oct 20261 filing
Company UpdateCertificate under SEBI (Depositories and Participants) Regulations, 2018

Caplin Point Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 15:13View Source
28 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Caplin Point Laboratories Limited – Trading Window closed from October 01, 2026 in connection with unaudited financial results for the quarter and half year ended September 30, 2026; trading window will open 48 hours after the said financial results are declared to the Stock Exchanges.

Caplin Point Laboratories Limited – Trading Window closed from October 01, 2026 in connection with unaudited financial results for the quarter and half year ended September 30, 2026; trading window will open 48 hours after the said financial results are declared to the Stock Exchanges.

Filed 17:05View Source
25 Sept 20264 filings
AGM/EGMAGM

Caplin Point Laboratories approves financials, declares dividend, and approves MD/WTD appointments at 35th AGM

AGM Details

  • AGM held on Friday, Sep 25, 2026 at 10:00 IST via VC/OAVM.
  • Voting cut-off date: Sep 18, 2026.
  • Shareholders on record date: 104,458.

Resolutions and outcomes

  • Resolution 1 (Ordinary): Adoption of standalone and consolidated financial statements; passed.
  • Resolution 2 (Ordinary): Final dividend declaration and interim dividend ratification; passed.
  • Resolution 3 (Ordinary): Re-appointment of Dr. Sridhar Ganesan by rotation; passed.
  • Resolution 4 (Special): Re-appointment of Dr. Sridhar Ganesan as Managing Director; passed.
  • Resolution 5 (Special): Continuation of Mr. C. C. Paarthipan as Chairman; passed.
  • Resolution 6 (Special): Appointment of Mr. D. Muralidharan as Whole-Time Director; passed.

Dividend

  • Final dividend approved; per-share amount not disclosed in filing.

Director & Management changes

  • Dr. Sridhar Ganesan re-appointed by rotation as Director.
  • Dr. Sridhar Ganesan appointed as Managing Director.
  • Mr. C. C. Paarthipan continues as Chairman; non-executive non-independent.
  • Mr. D. Muralidharan appointed as Whole-Time Director.
Filed 19:13View Source
AGM/EGMAGM

Caplin Point AGM 2026 conducted via VC/OAVM; six resolutions on financials, dividends, and director appointments put to vote with results awaited.

AGM Details

  • AGM held on 25 Sep 2026 at 10:00 AM IST via VC/OAVM.

Resolutions

  • Adoption of audited standalone and consolidated financial statements – Ordinary.
  • Declaration of final dividend and ratification of interim dividend – Ordinary.
  • Retirement by rotation of Sridhar Ganesan and proposed re-appointment – Ordinary.
  • Re-appointment of Sridhar Ganesan as Managing Director – Special.
  • Continuation of C. C. Paarthipan as Chairman and Non-Executive Non-Independent Director – Special.
  • Appointment of D. Muralidharan as Whole-Time Director – Special.

Voting status

  • Voting results will be consolidated and announced within two working days.

Dividend

  • Final dividend proposed; interim dividend ratified; amount not disclosed.
Filed 15:27View Source
Company UpdateGeneral

Caplin Point clarifies market-driven trading volume and confirms LODR disclosures

Volume movement

  • Clarifies that the recent volume rise is market-driven with no undisclosed information.
  • Disclosures under SEBI LODR Regulation 30 include all material events and price-sensitive information.
  • Company confirms no knowledge of specific reasons for the volume movement.
  • Reiterates commitment to ongoing compliance with disclosure requirements.
Filed 14:05View Source
Company UpdateClarification

The Exchange has sought clarification from Caplin Point Laboratories Ltd on September 25, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 13:25
24 Sept 20262 filings
Company UpdateSpurt in Volume

Significant increase in volume has been observed in Caplin Point Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Caplin Point Laboratories Limited has submitted their response.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 18:45View Source
Company UpdateSpurt in Volume

Significant increase in volume has been observed in Caplin Point Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 17:41View Source
4 Sept 20262 filings
Company UpdateCopy of Newspaper Publication

Caplin Point Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 15:21View Source
Company UpdateNewspaper Publication

Newspaper Publication for Notice of 35th AGM and E-Voting Information

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 15:19View Source
Showing 10 of 58 filings